NEW YORK, April 3, 2017 /PRNewswire/ -- Use this report to:
- Receive an overview of products currently in the marketplace and a detailed analysis of market position and competitive environments.
- Identify the markets in general segments: Vaccines/Therapeutics and Diagnostics.
Read the full report: http://www.reportlinker.com/p01413973/The-Global-Influenza-Market.html
- Analyze the patents issued for influenza technology by patent number and by issue year.
Highlights
- The global influenza market reached $5.1 billion in 2015. This market is expected to increase from $5.4 billion in 2016 to $6.4 billion in 2021 at a compound annual growth rate (CAGR) of 3.6% for 2016-2021.
- Vaccines market is expected to grow from $3.9 billion in 2016 to nearly $4.8 billion at a CAGR of 3.9% from 2016 through 2021.
- Diagnostics market is expected to grow from $485 million in 2016 to $635 million in 2021 at a CAGR of 5.5% from 2016 through 2021.
Introduction & Scope
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This BCC Research report, The Global Influenza Market: Vaccines, Therapeutics, and Diagnostics, is an update to the latest edition of the BCC Research report published in 2013. This report provides an overview of products currently in the marketplace and a detailed analysis of market position and competitive environments. The study includes information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers. There is a special emphasis on U.S. and European markets.
REASONS FOR DOING THE STUDY
Annually, up to a half-million people die of influenza and, with the threat of a pandemic in any given year, government agencies and disease prevention organizations are devoted to gaining control of the situation. The 2009 pandemic generated attention to surveillance measures, pandemic preparedness, vaccine production and antiviral control. It also revealed issues with laboratory capacity and the benefits of rapid testing in a pandemic situation. Many companies have been asked to assist with the problem and others are furthering their position with backing from government agencies. The next five years will continue to display support and funding for many research and development (R&D) programs, product development, and pandemic prevention and/or control by worldwide governments, organizations, and health professionals.
SCOPE OF REPORT
This BCC Research report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is worldwide, with emphasis on U.S. and European data. The report identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts and competitive analyses. Additionally, the study covers some of the most significant issues, trends and market factors.
METHODOLOGY AND
INFORMATION SOURCES
The information for this BCC report was obtained through primary and secondary data collection methods. Primary methods included interviews with key representatives in the industry: product development managers, clinical specialists, government departments and other key representatives involved in the influenza industry. Secondary methods included published literature, investment reports, company literature and various business journals that have emphasis on influenza products, technology and related information.
Read the full report: http://www.reportlinker.com/p01413973/The-Global-Influenza-Market.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article